![Weekly Enforcement Report: 23 People Charged in 2 Big Fraud Schemes](https://www.g2intelligence.com/wp-content/uploads/2023/02/Feb8-2023.News_.WeeklyEnforcement-GeneralHealthCare-iStock-1800x1250-1-1080x675.jpg)
Weekly Enforcement Report: 23 People Charged in 2 Big Fraud Schemes
Last week saw the usual False Claims Act and kickback-related charges, with the biggest action involving urine drug testing.
Last week saw the usual False Claims Act and kickback-related charges, with the biggest action involving urine drug testing.
Most of last week’s healthcare-related actions involved telemedicine in some way, with the lone lab-related case centering on genetic testing.
While labs were absent from recent enforcement actions, last week saw kickback schemes involving DME companies and a medical device company.
Case is a recent example of the trend toward Medicare schemes involving telehealth, cancer genetic testing, and kickbacks.
In last week’s key cases, those involved in UDT fraud schemes face the music, and a doctor is convicted of stealing COVID relief money.